Midas Care Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 47 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with FDA (GH), ZAMRA (ZM) and NAFDAC (NG). Customs aggregates show $2.0M of exports covering 76 molecules to 20 destinations in 2025.
| Site | FDA FEI |
|---|---|
| AURANGABAD, United Arab Emirates | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| FDA (GH) | 13 | None |
| ZAMRA (ZM) | 7 | None |
| NAFDAC (NG) | 6 | None |
| DIGEMAPS (DO) | 5 | None |
| EDE (AE) | 5 | None |
| ARCSA (EC) | 5 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $283K | 7 |
| 2025 | Not reported | $2.0M | 20 |
| 2024 | Not reported | $2.9M | 22 |
| 2023 | Not reported | $3.1M | 22 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Midas Care Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.